BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15830391)

  • 1. Sweat-testing: a review of current technical requirements.
    Beauchamp M; Lands LC
    Pediatr Pulmonol; 2005 Jun; 39(6):507-11. PubMed ID: 15830391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweat testing infants detected by cystic fibrosis newborn screening.
    Parad RB; Comeau AM; Dorkin HL; Dovey M; Gerstle R; Martin T; O'Sullivan BP
    J Pediatr; 2005 Sep; 147(3 Suppl):S69-72. PubMed ID: 16202787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].
    Sermet-Gaudelus I; Munck A; Rota M; Roussey M; Feldmann D; Nguyen-Khoa T;
    Arch Pediatr; 2010 Sep; 17(9):1349-58. PubMed ID: 20719482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sweat testing practices in German cystic fibrosis centres].
    Naehrlich L
    Klin Padiatr; 2007; 219(2):70-3. PubMed ID: 17405070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control.
    Sands D; Ołtarzewski M; Nowakowska A; Zybert K
    Folia Histochem Cytobiol; 2010 Sep; 48(3):358-65. PubMed ID: 21071339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN; Foster MM; Newman NB; Anbar RD
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of cystic fibrosis; simple genotyping to rule out the disease preferable to starting with the sweat test].
    van den Bergh FA; Martens A
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1001-5. PubMed ID: 12811969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between sweat chloride, sodium, and age in clinically obtained samples.
    Traeger N; Shi Q; Dozor AJ
    J Cyst Fibros; 2014 Jan; 13(1):10-4. PubMed ID: 23916616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current use of the sweat test (author's transl)].
    Götz M; Stur O
    Padiatr Padol; 1977; 12(4):413-6. PubMed ID: 904949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies in cystic fibrosis: determination of sweat electrolytes in situ with direct reading electrodes.
    Kopito L; Shwachman H
    Pediatrics; 1969 May; 43(5):794-8. PubMed ID: 5769505
    [No Abstract]   [Full Text] [Related]  

  • 14. False negative cystic fibrosis newborn screen.
    Collaco JM; Panny SR; Hamosh A; Mogayzel PJ
    Clin Pediatr (Phila); 2010 Mar; 49(3):214-6. PubMed ID: 20164071
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic testing in cystic fibrosis.
    Warren RH; Jones B; Heffington R
    J Ark Med Soc; 1983 May; 79(12):451-4. PubMed ID: 6223911
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis.
    Laguna TA; Lin N; Wang Q; Holme B; McNamara J; Regelmann WE
    Pediatr Pulmonol; 2012 Aug; 47(8):736-42. PubMed ID: 22786625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sweat testing: review of technical requirements].
    Rota M; Nguyen-Khoa T; Marchand M; Feldmann D; Dumont J; Khalfon D; Vassault A; Borgard JP;
    Ann Biol Clin (Paris); 2008; 66(2):221-7. PubMed ID: 18390434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of a novel conductometric device for the diagnosis of cystic fibrosis.
    Losty HC; Wheatley H; Doull I
    Ann Clin Biochem; 2006 Sep; 43(Pt 5):375-81. PubMed ID: 17022880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.
    Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW;
    J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.